BioSpace News Archive

Microcatheter-delivered device designed to provide rapid and focal occlusion of a wide range of peripheral arterial targets

This product will be used for PharmaCyte’s planned clinical trial in patients with locally advanced, inoperable pancreatic cancer

Research from the University of California, Davis, finds episodes of extremely hot weather lead to declines in market value.

Hillstream BioPharma, Inc. (“Hillstream”) today announced a collaboration with Ardena to secure manufacturing feasibility and capacity for Hillstream’s QUATRAMER portfolio.

In her $52 trillion Medicare for All proposal, Elizabeth Warren would repeal and replace the Affordable Care Act, Medicare, Medicaid, and all state laws and regulations on private insurance, observes the Association of American Physicians and Surgeons Instead, everyone would purportedly receive all necessary care, courtesy of the federal government, without worrying about the cost.

Board of Directors declared a quarterly dividend of $0.21 per share

Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its robust neurodegeneration portfolio with the launch of a new Alzheimer’s disease model, the ARTE10 mouse model.

The Cancer Center Business Summit is pleased to announce the launch of its industry-wide study to map the landscape of digital health technologies in cancer care.

Organization’s health plans only ones in the state to receive 5 out of 5 stars for quality mental health care, as well as overall quality of care

Mateon Therapeutics, Inc. (OTCQB:MATN) (‘Mateon”) announced today that they have completed their acquisition of PointR Data Inc. (PointR), a privately-held, developer of high performance cluster computer and artificial intelligence technologies.